Australia markets closed

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
43.34+0.55 (+1.29%)
At close: 04:00PM EDT
43.50 +0.16 (+0.37%)
After hours: 06:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close42.79
Open43.97
Bid43.23 x 100
Ask43.50 x 100
Day's range43.17 - 44.46
52-week range14.42 - 60.90
Volume341,907
Avg. volume875,265
Market cap2.539B
Beta (5Y monthly)1.76
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance

    SOUTH SAN FRANCISCO, Calif., September 12, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the U.S. Green Building Council (USGBC) awarded the company’s Wilsonville, OR facility LEED certification, meeting sustainability standards for its building, operations and maintenance.

  • Business Wire

    Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels

    SOUTH SAN FRANCISCO, Calif., September 09, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today released its 2024 corporate responsibility report detailing Twist’s approach to sustainability, social responsibility and ethics. The report highlights Twist’s ongoing commitment to advancing sustainable initiatives to best serve customers, communities and the planet.

  • Business Wire

    Twist Bioscience to Present at Baird Global Healthcare Conference 2024

    SOUTH SAN FRANCISCO, Calif., August 27, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird Global Healthcare Conference 2024 in New York City on Tuesday, September 10 at 2:35 p.m. Eastern Time.